MBOT on Nasdaq

Microbot Medical Inc.

American surgical and medical instruments and apparatus company.

Price unavailable

Last updated Oct 18, 2026.

Overview

Compare with Profusa, Inc., Sigyn Therapeutics, Inc. or Fractyl (United States), or pick any stock.

  • TickerMBOT on Nasdaq
  • IndustrySurgical & Medical Instruments & Apparatus
  • HeadquartersHingham, United States
  • Incorporated inDE2
  • Business address25 Recreation Park Dr Suite 108, Hingham, Ma 020432
  • Filer categoryNon-accelerated filer, Smaller reporting company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Operating income345678-$14.7M in 2025+104% since 2019
-$15.0M-$10.0M-$5.0M02019: -$7.2M-$7.2M20192020: -$9.1M-$9.1M2020+26%2021: -$11.4M-$11.4M2021+25%2022: -$13.3M-$13.3M2022+17%2023: -$9.9M-$9.9M2023−26%2024: -$11.6M-$11.6M2024+18%2025: -$14.7M-$14.7M2025+27%
Net income345678-$13.1M in 2025+81% since 2019
-$15.0M-$10.0M-$5.0M02019: -$7.2M-$7.2M20192020: -$9.2M-$9.2M2020+27%2021: -$11.3M-$11.3M2021+23%2022: -$13.2M-$13.2M2022+16%2023: -$10.7M-$10.7M2023−18%2024: -$11.4M-$11.4M2024+7%2025: -$13.1M-$13.1M2025+15%

Every line of the income statement as filed: the last 2 fiscal years, latest first.8

Period ending2025-12-312024-12-31
Research and development, net-$6.3M-$6.6M
Sales, general and administrative-$8.5M-$5.0M
Operating loss-$14.7M-$11.6M
Financing income, net$1.3M$182.0K
Other income$316.0K
Net loss-$13.1M-$11.4M
Basic net loss per share-$0.29-$0.73
Diluted net loss per share-$0.29-$0.73
Basic weighted average common shares outstanding45.8M shares15.6M shares
Diluted weighted average common shares outstanding45.8M shares15.6M shares

Compare Microbot Medical Inc. with another company

Leadership

Who has led Microbot Medical Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Martin M. McGlynn2006–2016
  2. Harel Gadot2016–now

Chair

  1. Harel Gadot2016–now

President

  1. Martin M. McGlynn2006–2016
  2. Harel Gadot2017–now

Chief financial officer

  1. Rodney Kb Young2006–2013
  2. Gregory T. Schiffman2014–2016
  3. David Ben Naim2016–2018
  4. Rachel Vaknin2022–now

Chief operating officer

  1. Ann Tsukamoto2007–2009
  2. Yehezkel Himelfarb2016–2017
2010201520202025
Board members and other officers (24)

Former names

  • STEMCELLS INCDec 5, 2000 to Nov 15, 20162
  • CYTOTHERAPEUTICS INC/DEFeb 14, 1994 to May 15, 20002

Timeline

  1. Nov 30, 2016New chief executive Harel Gadot becomes CEO11
  2. Mar 31, 2006New chief executive Martin M. McGlynn becomes CEO12
  3. Aug 2, 1988Founded Microbot Medical Inc. is founded43

Filings

400 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 183 major events, 57 insider forms, 11 large holders, 5 private raises, 124 other. The latest 20:

  1. Oct 6, 20268-K EDGAR
  2. Sep 28, 20268-K EDGAR
  3. Aug 11, 20268-K EDGAR
  4. Aug 11, 202610-Q EDGAR
  5. Aug 7, 20268-K EDGAR
  6. Jul 21, 20268-K EDGAR
  7. Jul 7, 20268-K EDGAR
  8. Jun 30, 20268-K EDGAR
  9. Jun 25, 20268-K EDGAR
  10. Jun 23, 20268-K EDGAR
  11. Jun 16, 20268-K EDGAR
  12. Jun 9, 20268-K EDGAR
  13. Jun 2, 20268-K EDGAR
  14. May 26, 20268-K EDGAR
  15. May 15, 20268-K EDGAR
  16. May 14, 20268-K EDGAR
  17. May 13, 202610-Q EDGAR
  18. May 5, 20268-K EDGAR
  19. Apr 30, 20268-K EDGAR
  20. Apr 22, 20268-K EDGAR

The 400 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last three years, summarized. The full record is on SEC EDGAR.

Insider trades and holders

Large holders

Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 11 such filings since October 2021, the latest 10:

  1. Jan 23, 2026SCHEDULE 13G
  2. Nov 7, 2025SCHEDULE 13G/A
  3. Oct 31, 2025SCHEDULE 13G/A
  4. Aug 12, 2025SCHEDULE 13G/A
  5. Jul 29, 2025SCHEDULE 13G
  6. May 12, 2025SCHEDULE 13G/A
  7. May 9, 2025SCHEDULE 13G/A
  8. Jan 13, 2025SCHEDULE 13G
  9. Jan 10, 2025SCHEDULE 13G
  10. Feb 14, 2024SC 13G/A

From Forms 4 and Schedules 13D and 13G filed with the SEC.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Sep 16, 2025Raised $25.2 million in a private offering of securities Form D: 1 investor so far Form D
  2. Feb 11, 2025Raised $13 million in a private offering of equity Form D: 5 investors so far Form D
  3. Jan 10, 2025Raised $8.6 million in a private offering of equity Form D: 5 investors so far Form D
  4. Jan 7, 2025Raised $7 million in a private offering of equity Form D: 5 investors so far Form D
  5. Jun 3, 2024Raised $1.8 million in a private offering of equity Form D: 3 investors so far Form D

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 70. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Vanguard Capital Management LLC2,906,810$5.7M0.0%−2,715
Mitsubishi UFJ Asset Management Co., Ltd.1,268,453$2.5M0.0%New
BlackRock, Inc.902,411$1.8M0.0%+45,013
Geode Capital Management, LLC836,271$1.6M0.0%+75,440
UBS Group AG806,847$1.6M0.0%−10,098
DNB Asset Management AS677,498$1.3M0.0%No change
Stifel Financial Corp589,924$1.2M0.0%+16,849
Marshall Wace, Llp541,963$1.1M0.0%+60,918
Susquehanna International Group, Llp525,827$1.0M0.0%−398,480
Vanguard Fiduciary Trust Co431,033$840.5K0.0%+30,808
State Street Corp303,569$592.0K0.0%No change
AlphaCentric Advisors LLC250,000$487.5K0.4%+50,000
Northern Trust Corp147,530$287.7K0.0%+4,170
Group One Trading LLC106,429$207.5K0.0%+59,866
Jane Street Group, LLC106,134$207.0K0.0%−35,407
American Century Companies Inc93,314$182.0K0.0%+80,896
Millennium Management LLC86,302$168.3K0.0%−368,444
Invesco Ltd.52,201$101.8K0.0%+22,781
Charles Schwab Investment Management Inc50,000$97.5K0.0%No change
Vontobel Holding Ltd.48,088$93.8K0.0%No change
Envestnet Asset Management Inc47,426$92.5K0.0%+2,804
Bridgeway Capital Management, LLC44,300$86.4K0.0%−50,000
Cetera Investment Advisers43,812$85.4K0.0%+1,400
Lazari Capital Management, Inc.36,600$71.4K0.0%+13,345
Hilltop Holdings Inc.35,764$69.7K0.0%No change

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43